Keywords: teva, million, alliance, btg, israeli, drugmaker, pharmaceutical

Teva in $20 million alliance with BTG

Article | 11 October 1999

Israeli drugmaker Teva Pharmaceutical and Bio-Technology General Corphave signed a strategic alliance to develop and sell "several generic recombinant therapeutic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing